Completeness of Reporting Oligometastatic Disease Characteristics in the Literature and Influence on Oligometastatic Disease Classification Using the ESTRO/EORTC Nomenclature
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference55 articles.
1. Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document;Lievens;Radiother Oncol,2020
2. Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature;Ashworth;Lung Cancer,2013
3. Characterisation and classification of oligometastatic disease: A European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation;Guckenberger;Lancet Oncol,2020
4. Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study;Willmann;Radiother Oncol,2022
5. Baker S, Jiang W, Mou B, et al. Progression-free survival and local control following stereotactic ablative radiotherapy for up to 5 oligometastases: An analysis from the population-based phase II SABR-5 trial [e-pub ahead of print]. Int J Radiat Oncol Biol Phys. Available at: https://doi.org/10.1016/j.ijrobp.2022.05.033. Accessed June 6, 2022.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Radiation Oncologists’ Perspectives on Oligometastatic Prostate Cancer: A Survey from Korean Oligometastasis Working Group;Current Oncology;2024-06-03
2. Prognostic Factors of Oligometastasis After Stereotactic Body Radiotherapy: The Real-World Utility of the European Society for Radiotherapy and Oncology/European Organisation for Research and Treatment of Cancer Classification;Cureus;2024-05-19
3. Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma;Current Oncology Reports;2024-04-11
4. Metastasis-directed therapy in oligometastatic prostate cancer;Current Opinion in Urology;2024-03-05
5. Metastases-directed local therapies (MDT) beyond genuine oligometastatic disease (OMD): Indications, endpoints and the role of imaging;Clinical and Translational Radiation Oncology;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3